Wolverine Trading’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $163K | Sell |
20,500
-1,000
| -5% | -$7.12K | ﹤0.01% | 5027 |
|
|
2025
Q2 | $127K | Buy |
21,500
+2,200
| +11% | +$14.2K | ﹤0.01% | 4103 |
|
|
2025
Q1 | $163K | Buy |
19,300
+1,700
| +10% | +$15.7K | ﹤0.01% | 4054 |
|
|
2024
Q4 | $166K | Sell |
17,600
-98,200
| -85% | -$1.02M | ﹤0.01% | 4629 |
|
|
2024
Q3 | $1.24M | Buy |
115,800
+99,600
| +615% | +$1.08M | ﹤0.01% | 2146 |
|
|
2024
Q2 | $161K | Buy |
+16,200
| New | +$166K | ﹤0.01% | 3920 |
|
|
2024
Q1 | – | Sell |
-21,200
| Closed | -$301K | – | 4742 |
|
|
2023
Q4 | $301K | Sell |
21,200
-3,500
| -14% | -$39.7K | ﹤0.01% | 3459 |
|
|
2023
Q3 | $300K | Buy |
+24,700
| New | +$319K | ﹤0.01% | 3298 |
|
|
2022
Q4 | – | Sell |
-10,400
| Closed | -$107K | – | 4316 |
|
|
2022
Q3 | $107K | Buy |
+10,400
| New | +$116K | ﹤0.01% | 3890 |
|
|
2021
Q3 | – | Sell |
-29,000
| Closed | -$289K | – | 6464 |
|
|
2021
Q2 | $289K | Sell |
29,000
-24,600
| -46% | -$240K | ﹤0.01% | 4469 |
|
|
2021
Q1 | $503K | Buy |
53,600
+37,900
| +241% | +$587K | ﹤0.01% | 3688 |
|
|
2020
Q4 | $360K | Buy |
+15,700
| New | +$321K | ﹤0.01% | 3541 |
|
|
2020
Q3 | – | Sell |
-15,900
| Closed | -$247K | – | 4722 |
|
|
2020
Q2 | $247K | Sell |
15,900
-14,100
| -47% | -$172K | ﹤0.01% | 3559 |
|
|
2020
Q1 | $291K | Sell |
30,000
-8,600
| -22% | -$81.8K | ﹤0.01% | 3254 |
|
|
2019
Q4 | $368K | Buy |
38,600
+23,900
| +163% | +$219K | ﹤0.01% | 3355 |
|
|
2019
Q3 | $119K | Sell |
14,700
-14,100
| -49% | -$153K | ﹤0.01% | 3799 |
|
|
2019
Q2 | $359K | Buy |
28,800
+14,000
| +95% | +$178K | ﹤0.01% | 3079 |
|
|
2019
Q1 | $201K | Sell |
14,800
-8,800
| -37% | -$107K | ﹤0.01% | 3822 |
|
|
2018
Q4 | $218K | Sell |
23,600
-38,700
| -62% | -$425K | ﹤0.01% | 3605 |
|
|
2018
Q3 | $753K | Sell |
62,300
-26,200
| -30% | -$366K | ﹤0.01% | 2646 |
|
|
2018
Q2 | $1.33M | Hold |
88,500
| – | – | ﹤0.01% | 1960 |
|
|
2018
Q1 | $1.33M | Buy |
88,500
+8,000
| +10% | +$122K | ﹤0.01% | 1960 |
|
|
2017
Q4 | $1.16M | Buy |
80,500
+2,700
| +3% | +$37.1K | ﹤0.01% | 2057 |
|
|
2017
Q3 | $1.17M | Buy |
77,800
+32,200
| +71% | +$426K | ﹤0.01% | 1760 |
|
|
2017
Q2 | $453K | Buy |
45,600
+15,600
| +52% | +$126K | ﹤0.01% | 2538 |
|
|
2017
Q1 | $216K | Sell |
30,000
-19,800
| -40% | -$125K | ﹤0.01% | 3429 |
|
|
2016
Q4 | $248K | Sell |
49,800
-6,300
| -11% | -$43.6K | ﹤0.01% | 3472 |
|
|
2016
Q3 | $397K | Sell |
56,100
-14,100
| -20% | -$95.2K | ﹤0.01% | 2847 |
|
|
2016
Q2 | $380K | Buy |
+70,200
| New | +$491K | ﹤0.01% | 2529 |
|
Other funds holding FOLD
ACA
VPC
Wolverine Trading's FOLD Position: Q3 2025 in Review
Wolverine Trading reduced its Amicus Therapeutics (FOLD) stake by 57% in Q3 2025, selling an estimated $107K and leaving 11,399 shares worth $90.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5231.
Wolverine Trading first reported a position in FOLD in Q4 2016 and has held it in 21 quarters since. The position peaked at $640K in Q3 2024. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.
- Wolverine Trading held 11,399 shares of Amicus Therapeutics worth $90.5K as of Q3 2025.
- Wolverine Trading sold 15,039 Amicus Therapeutics shares in Q3 2025, an estimated $107K.
- Amicus Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5231 holding.
- Wolverine Trading first reported a position in Amicus Therapeutics in Q4 2016 and has held it in 21 quarters since.
- Wolverine Trading's Amicus Therapeutics position peaked at $640K in Q3 2024.
- 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.